Cellulite Treatment Micro-Coring for Septa-Like Scar Formation

The patent replaces traditional mechanical surgical cutting with a laser-based system that uses light energy to precisely incise and cut the fibrous septa. The laser beam (e.g., CO2 laser) vaporizes or ablates the connective tissue bonds between fat lobules without requiring physical contact or mechanical force, thereby eliminating bleeding, bruising, and mechanical trauma while maintaining effective cellulite treatment.

The patent employs controlled laser parameters (wavelength, pulse duration, energy density) to selectively target and disrupt the fibrous septa at specific depths in the subcutaneous tissue. By adjusting these parameters, the system achieves precise thermal destruction of the problematic connective tissue bands while preserving surrounding healthy tissue, thus improving treatment reliability without increasing trauma.

The patent divides the treatment approach into two distinct components: (1) laser-induced cutting of fibrous septa to release the mechanical constraints causing cellulite dimpling, and (2) application of negative pressure suction to immediately aspirate the released fat lobules. This segmentation allows each component to perform its specific function optimally, achieving reliable results without the need for invasive surgery or prolonged conservative therapy.

The patent merges two previously separate treatment modalities into a single integrated system: the laser cutting mechanism and the negative pressure suction device are combined in one apparatus. The laser creates precise incisions in the fibrous septa, and the suction mechanism simultaneously or sequentially removes the liberated fat, providing immediate and visible results in one treatment session rather than requiring separate procedures or extended conservative management.